XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Mar. 22, 2023
Dec. 30, 2022
Cover [Abstract]      
Document Type 10-K/A    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --12-31    
Entity File Number 001-41264    
Entity Registrant Name NUVECTIS PHARMA, INC.    
Entity Central Index Key 0001875558    
Entity Tax Identification Number 86-2405608    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 1 Bridge Plaza    
Entity Address, Address Line Two Suite 275    
Entity Address, City or Town Fort Lee    
Entity Address, State or Province NJ    
Entity Address, Postal Zip Code 07024    
City Area Code 201    
Local Phone Number 614-3150    
Title of 12(b) Security Common Stock, par value $0.00001 per    
Trading Symbol NVCT    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 64.0
Entity Common Stock, Shares Outstanding   14,752,403  
ICFR Auditor Attestation Flag false    
Auditor Name PricewaterhouseCoopers International Limited    
Auditor Location Tel-Aviv, Israel    
Auditor Firm ID 1309